This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The nutraceutical market is expanding rapidly, valued at $6.11 billion in 2024 and projected to reach $11.55 billion by 2030, according to a GlobeNewsWire report. However, pharma companies eager to tap into this growth, face a complex road ahead. Regulatory ambiguity, for instance, serves as a double-edged sword. On the one hand, relatively less regulatory control eases market entry; on the other, they expose pharma players to intense competition from both established FMCG brands and agile start
The National Institutes of Health has made a landmark decision that could irreparably damage the backbone of American scientific innovation: a dramatic reduction in the indirect cost rate for research grants. This sweeping policy change sets the indirect rate to 15%, a stark contrast with the 60% or more that many institutions currently rely on for essential administrative and operational costs.
When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions or blame over responsibility At a tense meeting with senior civil servants on the afternoon of 29 January, the chair of AstraZeneca, Shaun Grady, pulled the plug on a planned 450m expansion of its childhood flu vaccine factory in Merseyside bringing a year and a half of negotiations to an abrupt halt.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Dr Navin Saxena, Chairman of Rusan Pharma, has been awarded two of Russias highest honours: The Order of Friendship by the Russian Federation and the Memorial Medal from Moscows Peoples Friendship University. These awards recognise his contributions to science, medicine, pharmaceutical innovation, and cross-cultural collaboration over a 40-year career.
It’s no secret that life expectancy in the United States is among the lowest in the developed world and has been since long before the Covid-19 pandemic. The United States ranked 29 th in life expectancy at birth among peer nations in the Organization for Economic Cooperation and Development despite spending almost twice as much on clinical care per person as the average OECD nation.
It’s no secret that life expectancy in the United States is among the lowest in the developed world and has been since long before the Covid-19 pandemic. The United States ranked 29 th in life expectancy at birth among peer nations in the Organization for Economic Cooperation and Development despite spending almost twice as much on clinical care per person as the average OECD nation.
The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. Behind the scenes, companies are employing clever tactics to protect their intellectual property and block competitors from entering the market.
NHS England (NHSE) and the government must publish its economic review of community pharmacy for the sake of transparency in contract negotiations, the two independent pharmacy organisations have demanded. The review, promised as part of the 2022-24 pharmacy contract, aims to find out the 'full economic costs of delivering NHS pharmaceutical services' and whether NHS […] The post Economic review of pharmacy must be published now, urge IPA and NPA appeared first on The Pharmacist.
DKSH reported core EBIT growth and strong cash conversion in 2024, with net sales reaching CHF 11.1 billion, representing a 4.0 per cent increase at constant exchange rates. Core EBIT rose to CHF 343.1 million, an 8.4 per cent increase at constant exchange rates, leading to a core EBIT margin of 3.1 per cent, marking the fourth consecutive year of margin expansion.
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant twinkle in the company’s eye.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The two companies will let their long-running contract expire this year, and drugmakers will need to decide which is the best platform for them in a changing marketplace.
Online treatment service providers have been encouraged 'to review their commercial relationships with third parties' to ensure they abide by medicines advertising regulations, particularly regarding weight-loss medications. This comes as one company, Habitual Healthcare, has changed how it collaborates with online influencers, on the advice of the Medicines and Healthcare Regulatory Agency (MHRA).
Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. With the increasing demand for affordable medications, generic drug manufacturers are under pressure to expedite their development timelines without compromising on quality.
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. And the move comes after Moderna was chastised for the second time in five months by a U.K. trade group over its attempts to recruit children into a late-stage clinical trial for its Covid shot.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Roquette, a global provider of plant-based ingredients and pharmaceutical and nutraceutical excipients, has launched its refreshed coatings platform for pharmaceutical and nutraceutical applications. The platform combines two product rangesTabshield ready-to-use film coating systems and ReadiLYCOAT plant-based ready-to-use coating systemsoffering manufacturers a broader selection of coating solutions.
Overweight patients who are living with long Covid could benefit from a supported weight management programme to help alleviate symptoms, a new study suggests. Researchers at the University of Glasgow found that a remotely delivered structured weight management program, supported by a dietitian and offering peer support, could improve a range of long Covid symptoms […] The post Supported weight management may improve long Covid symptoms appeared first on The Pharmacist.
The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. But the truth is, partnerships are the backbone of generic drug development, and their impact cannot be overstated.
Apple on Wednesday announced a new longitudinal research study that will investigate relationships between different aspects of health that can be measured using its devices, potentially informing the development of new health features. Called simply the Apple Health Study, the project is a collaboration with researchers at Brigham and Women’s Hospital and will enroll volunteers through Apple’s Research app, who will share as much or as little of their health data as they like.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Academy of Digital Health Sciences, in collaboration with Bombay College of Pharmacy and the Indian Institute of Management (IIM) Raipur, has launched the Professional Development Programme in Digital Health for Pharmacists. The initiative aims to equip pharmacists with essential digital health skills to enhance pharmaceutical care, streamline workflows, and improve patient outcomes.
A new faculty to support pharmacists and pharmacy technicians working in or with care homes has been launched, with an introductory webinar to be held this evening. The National Care Home Faculty (NCHF) is open to any pharmacist or pharmacy technician with an interest in care home pharmacy and medicines use in care homes […] The post Faculty to support care home pharmacists launched appeared first on The Pharmacist.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I apologize for this depressing, cynical newsletter. I still hope you read it. Why it’s so bleak out there My recent conversations with folks in the biotech investing world can only be described as bleak.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
As healthcare shifts toward value-based care, medication reconciliation has become a critical focus for reducing costs and improving patient outcomes. Discrepancies in medication regimens, particularly during care transitions like hospital discharge, are a leading cause of adverse drug events (ADEs). These preventable issues result in significant financial burdens on healthcare systems while compromising patient safety and care quality.
The Institute of Chemical Technology, Mumbai, in partnership with the Mumbai Biocluster, hosted the 5th Annual Summit of Biologics Conference and Workshops on Biopharmaceutical Product Development from January 30th to 31st 2025. The event, held at the Novotel Dona Sylvia Resort, Goa, attracted over 700 attendees, including 150 distinguished speakers, 12 sponsors, and 41 exhibitors.
Fractyl Health is entering pivotal studies for a procedure that aims to be an ‘off ramp’ to GLP-1s and exploring how a one-time, ‘smart GLP-1’ gene therapy can Treat type 2 diabetes.
Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu know the pains of starting biotech companies firsthand. The trio crossed paths a decade ago in CRISPR pioneer Feng Zhang ’s lab before going on to found organizations like the Arc Institute , Stylus Medicine, and Tome Biosciences. Over the years, they’ve commiserated about their respective struggles making the best RNA molecules in-house or facing lengthy wait times when ordering raw materials.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
99 
Let's personalize your content